Clinical trials: Functional Dyspepsia
Dyspepsia
Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
Itopride is a compound already marketed in Japan and in some countries of Eastern Europe under the name of Ganaton. It is used to treat symptoms of functional dyspepsia.
- Trial name
- NCT00112203
- Testing
- Itopride
- Volunteers
- 466 people
- Sponsor
- Forest Laboratories
Functional Dyspepsia
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
The purpose of this study is to verify the superior efficacy of Z-338 to placebo in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms.
- Trial name
- NCT00761358
- Testing
- Z-338
- Where
- 2 sites in Japan
- Volunteers
- 820 people
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
- Trial name
- NCT00323817
- Testing
- Z-338
- Where
- Belgium
- Volunteers
- 282 people
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults
This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.
- Trial name
- NCT00850746
- Testing
- YM443, Moxifloxacin
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Astellas Pharma Inc
NSAID Related Gastric Irritation
Pilot Study of OXP001 and Brufen in Healthy Subjects
Oxford Pharmascience (the sponsor) is developing a new formulation of Ibuprofen (OXP001 - the study drug) which it is proposed will have less of the side effects than are currently reported with standard prescription strength…
- Trial name
- NCT02050958
- Testing
- OXP001, Ibuprofen
- Where
- United Kingdom
- Volunteers
- 43 people, healthy volunteers welcome
- Sponsor
- Oxford Pharmascience Ltd
Dyspepsia
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
The main purpose of the study is to assess the efficacy of domperidone in treatment of functional dyspepsia (FD) in Chinese participants and identify sub-populations (subtype of the disease) who are sensitive to domperidone…
- Trial name
- NCT03617016
- Testing
- Domperidone
- Where
- 5 sites in China
- Volunteers
- 160 people
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
Functional Dyspepsia
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
The purpose of this study is to evaluate pharmacokinetics, efficacy and safety of Z-338 of pediatric patients with functional dyspepsia (FD).
- Trial name
- NCT04526119
- Testing
- Acotiamide hydrochloride hydrate
- Where
- Japan
- Volunteers
- 55 people
- Sponsor
- Zeria Pharmaceutical
Indigestion, Dyspepsia
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
The goal of this observational study is to evaluate if Danning Tablets are effective in alleviating dyspepsia in patients with any of the following digestive symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux…
- Conditions
- Indigestion, Dyspepsia, Bloating, Loss of Appetite
- Trial name
- NCT06755671
- Testing
- Danning Tablet
- Where
- China
- Volunteers
- 4,500 people
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited
Dyspepsia
EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA
This is a prospective, randomized, double - blind study of 474 male and female volunteers with dyspeppsia diagnosed at the Oswaldo Cruz University Hospital Gastroenterology Outpatient Clinic from March 2025 to March 2027.
- Trial name
- NCT04069286
- Testing
- Oral Aroeira, Omeprazole 20Mg Capsule
- Volunteers
- 474 people
- Sponsor
- Infan Industria Quimica Farmaceutica Nacional
Dyspepsia
Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal
Itopride is a new compound that is already marketed in Japan and in some countries of Eastern Europe under the name of Ganaton. It is used to treat symptoms of functional dyspepsia.
- Trial name
- NCT00112190
- Testing
- Itopride Hydrochloride, itopride
- Where
- Canada
- Volunteers
- 645 people
- Sponsor
- Forest Laboratories
Functioanl Dyspepsia
The Effect of Z-338 in Subjects With Functional Dyspepsia
Z-338; PhaseIIb, Single-centre, Randomized, Double-blind, Placebo-controlled, Parallel group study in Subjects with Functional Dyspepsia, evaluate the motility of gastro-duodenum by ultrasound
- Trial name
- NCT00458328
- Testing
- Z-338
- Where
- Japan
- Volunteers
- 40 people
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia
To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.
- Trial name
- NCT00333372
- Testing
- Z-338
- Where
- Japan
- Volunteers
- 440 people
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
A Study to Demonstrate the Efficacy and Safety of Motilitone®
This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia.
- Trial name
- NCT01817465
- Testing
- Motilitone ®, Pantoline®, Motilitone® and Pantoline®
- Where
- South Korea
- Volunteers
- 389 people
- Sponsor
- Dong-A ST Co., Ltd.
Functional Dyspepsia
Probiotics in Functional Dyspepsia
The goal of this clinical trial is to learn whether a multi-strain probiotic can reduce digestive symptoms and improve quality of life in adults with functional dyspepsia.
- Trial name
- ProPepsis (NCT07276009)
- Testing
- Lactobacillus
- Where
- Ukraine
- Volunteers
- 60 people
- Sponsor
- Nordic Biotic Sp. z o.o.
Functional Dyspepsia
Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.
A phase Ⅲ, multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.
- Trial name
- NCT02831543
- Testing
- Motireb 5/100 mg, Mosapride citrate
- Where
- South Korea
- Volunteers
- 354 people
- Sponsor
- IlDong Pharmaceutical Co Ltd